Insulin prices and PBM rebates: pin the tail on the patient - STAT

Insulin prices and PBM rebates: pin the tail on the patient - STAT

Insulin prices and pharmacy benefit manager rebates: pin the tail on the patient

By DUANE SCHULTHESS

ADOBE

Some pharma companies report lower U.S. sales for insulin than Medicare Part D spent on their drugs. Could that be the invisible hand of PBMs at work?

READ MORE